Pertussis is a highly transmittable and acute respiratory illness caused mainly by the strictly human pathogen Bordetella pertussis. Despite being a vaccine-preventable disease, pertussis still causes approximately 200,000-400,000 deaths worldwide each year-primarily in unimmunized young infants who become infected by susceptible adolescents and in adults, among whom the disease generally manifests mildly and is often not recognized [1] [2] [3] .
One of the key immune modulators of B. pertussis is its endotoxin component, a major constituent of the outer membrane of gram-negative bacteria [4] . B. pertussis endotoxins lack a serospecific O polysaccharide [5] and, thus, are referred to as lipooligosaccharides (LOS). Canonical endotoxins are potent inducers of Toll-like receptor 4 (TLR4)-mediated signaling that results in the induction of antimicrobial genes and release of cytokines, thereby initiating inflammatory and immune defense responses [6] . In humans, the role of B. pertussis endotoxin in infection and immunity remains unclear. In mouse infection models, B. pertussis endotoxin recognition and signaling via TLR4 has been implicated in clearance of the bacteria [7] and the generation of protective immunity from a whole-cell pertussis vaccine [8] . However, acellular pertussis vaccines (which contain purified protein antigens only) can be equally efficacious as whole-cell pertussis vaccines in humans [2] and mice [9] ; thus, a host response to endotoxin is not essential for immunity to B. pertussis. In contrast, endotoxin activity contributes to reactogenicity of diphtheria-tetanus toxoids-whole cell pertussis (DTwP) vaccines [10] , which prompted the development of acellular pertussis-component vaccines [3] . We demonstrated previously that the lipid A phosphate groups of B. pertussis BP338 can be modified by addition of glucosamine (GlcN), which is positively regulated by the BvgAS 2-component system, and this greatly enhances the inflammatory response in cells that express human but not murine TLR4-MD-2-CD14 [11, 12] .
In the present study, we investigated whether endotoxin activity varies between different B. pertussis isolates. Among the tested B. pertussis strains were BP338 and 18-323. B. pertussis 18-323 is routinely used for intracerebral challenge of mice [13] , which for decades has been the gold standard for evaluating the potency of DTwP vaccines. B. pertussis 18-323 displays considerable phylogenetic divergence, compared with other B. pertussis isolates [14] [15] [16] [17] [18] , and has been established as a mouse challenge strain mainly on the basis of its high virulence on intracerebral challenge of mice [13] . BP338 is a derivative of Tohama I [19] , a B. pertussis strain used to formulate conventional DTwP vaccines for mass vaccination in Japan until 1975 when Japan discontinued childhood vaccinations with DTwP vaccines because of growing controversy about their safety [20] . Our results demonstrate functional and structural differences between endotoxins of 2 historically important B. pertussis strains, which have critical implications for the interpretation of previous studies of host defenses to infection which used different B. pertussis strains in mice and in vitro.
METHODS
Bacterial strains and growth conditions. B. pertussis BP338 [19] and 18-323 were obtained from Alison Weiss (University of Cincinnati). Mutant BP338GlcN
Ϫ was generated and characterized elsewhere [12] . B. pertussis CCL-2 [21] was obtained from Mark Peppler (University of Alberta). All strains were first grown on Bordet-Gengou agar, and then in Stainer-Scholte broth, harvested into phosphate-buffered saline, concentrated to an optical density at 600 nm of 5 ( colony-forming 9 7.5 ϫ 10 units per mL), and heat inactivated as described elsewhere [12] . 18-323 and CCL-2 were cultivated without antibiotics. The heat-killed whole-cell preparations were stored at Ϫ80ЊC and lyophilized prior to LOS extraction.
Highly purified B. pertussis LOS preparation. B. pertussis LOS preparations were extracted by an ammonium hydroxideisobutyric acid method (Caroff M, Novel method for isolating endotoxins, patent 2004/062690). Primary extracts were subjected to a standard enzyme treatment (DNAse, RNAse, and proteinase K) and further purified with the acidified chloroform-methanol-water procedure [22] . To be sure that no specific LOS molecular species were discriminated during the purification process, all intermediate and final products were analyzed by matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS). High purity of the final LOS preparations was evidenced as described elsewhere [12] .
Other TLR ligands. Ultrapure Escherichia coli and Rhodobacter sphaeroides endotoxins, lipid IV A , and Pam 3 CSK 4 were obtained from InvivoGen, Peptides International, and EMC Microcollections, respectively.
Direct lipid A isolation from bacterial cells. For MALDI MS analysis, lipid A was isolated directly from bacterial cells by hydrolysis with a mixture of isobutyric acid and 1 mol/L ammonium hydroxide followed by extraction with chloroformmethanol-water [12, 23, 24] .
Sequential liberation of ester-linked fatty acids by mild alkali treatment. To establish lipid A acylation patterns, a 2-step procedure was applied to lipid A and LOS preparations [23, 24] . Briefly, to liberate only primary ester-linked fatty acids, dried lipid A extract or LOS in a quantity equivalent to ∼50 mg of pure lipid A was dispersed in 28% ammonium hydroxide solution at 1 mg/mL and kept at 50ЊC with stirring for 5 h. Then, ammonia was removed under a stream of nitrogen. The sample was diluted with water, lyophilized, and analyzed by MALDI MS. To liberate all primary and secondary ester-linked fatty acids, this procedure was repeated, replacing ammonium hydroxide with 41% methylamine at 37ЊC. To obtain more detailed structural information, the fatty acid liberation was followed with 28% ammonium hydroxide at 50ЊC. MALDI spectra were recorded at different times (0, 8 min, 15 min, 30 min, 1 h, and 2 h).
MALDI MS analysis of LOS and lipid A. Untreated and modified LOS samples were dispersed in water at 1 mg/mL. Initial lipid A extracts in chloroform-methanol-water were used directly. Sample preparation and MALDI MS analysis on a PerSeptive Voyager-DE STR time-of-flight mass spectrometer (Applied Biosystems) were performed as described elsewhere [12] .
Fatty acid analysis. Fatty acid analysis was performed by gas chromatography after hydrolysis of purified LOS (100 mg) in 4 mol/L HCl (2 h at 100ЊC), extraction of fatty acid with ethyl acetate, and esterification of the sample (dry methanolacetyl chloride for 6 h at 85ЊC) [25] . The HP 5890 gas chromatograph was equipped with a SGE 25QC3/BP10 0.5 capillary column, and a temperature gradient from 130ЊC to 240ЊC (gradient, 2ЊC per min) was used.
Cell culture. HEK-293, THP-1, and RAW 264.7 cells were maintained in high glucose Dulbecco's modified Eagle's medium or RPMI 1640 medium containing 10% heat-inactivated fetal calf serum and supplements as described elsewhere [12] .
HEK-293 transfections, stimulations, and luciferase assays. HEK-293 cells were transiently transfected with a nuclear factor (NF)-kB reporter construct (ELAM-1 firefly luciferase), the bactin-Renilla luciferase reporter construct, the modified pDisplay expression vector, and the expression constructs for murine and human TLR4-MD-2-CD14, as described elsewhere [12] . The cells were stimulated in 100 mL of medium supple- (1 mg/mL) or were left unstimulated. After 4 h of stimulation, cells were lysed with 50 mL of passive lysis buffer (Promega), and luciferase activity was measured in 10 mL of the lysate with use of the Dual Luciferase reporter assay system (Promega).
THP-1 and RAW 264.7 stimulations and cytokine detection. Prior to stimulation, THP-1 cells were differentiated into macrophages by incubation with phorbol 12-myristate 13-acetate (Sigma-Aldrich) [12] . Stimulations of both THP-1-derived macrophages and RAW 264.7 cells were performed by replacing the cell culture medium with fresh medium supplemented with purified LOS, heat-killed whole bacteria, or with no added stimulus [12] . To quantify cytokines secreted by LOS-stimulated THP-1 cells, undiluted tissue culture supernatants were assayed using human Pro-Inflammatory 4-Plex I tissue culture kits, a Sector Imager 2400, and data analysis software from Meso Scale Discovery. To quantify cytokines secreted by THP-1 cells stimulated with whole inactivated cells, undiluted tissue culture supernatants were assayed using a Luminex 100 system, a human cytokine 25-Plex kit (Biosource International), and STarStation data analysis software (Applied Cytometry Systems). To quantify cytokines secreted by RAW 264.7 cells, 1:3 dilutions of the tissue culture supernatants were assayed using a Bio-Plex 200 system and Bio-Plex Pro Assay kits (Bio-Rad). All assays were performed according to the manufacturers' instructions.
Statistical analysis. Data groups were compared by 2-way analysis of variance with repeated measures or by 1-way analysis of variance with Bonferroni posttests, as indicated in the figure legends. A value of was considered to indicate a statis-P ! .05 tically significant difference.
RESULTS
To rapidly test the endotoxin activity of different B. pertussis strains, we examined heat-killed cells for their capacities to activate NF-kB in transfected HEK-293 cells expressing human or murine TLR4-MD-2-CD14 [12] . The tested strains included the Tohama I derivative BP338 and its isogenic mutant BP338GlcN Ϫ , which lacks the ability to modify its lipid A phosphate groups [11, 12] , mouse challenge strain 18-323, and the abandoned vaccine strain CCL-2. In marked contrast to the 2 other B. pertussis wild-type strains, BP338 and CCL-2 (data not shown), we found strain 18-323 to poorly induce NF-kB activation via human TLR4-MD-2-CD14, with even less induction than BP338GlcN Ϫ ( Figure 1A antigen and is therefore more suitable for comparing dosedependent biological activities. E. coli K12 LOS was the most potent inducer of signaling, via either the human or murine TLR4-MD-2-CD14 receptors, and LOS from B. pertussis 18-323 was significantly less capable of inducing NF-kB activation than LOS from B. pertussis BP338. NF-kB activation levels in response to both B. pertussis LOS species were considerably higher when signaling proceeded through murine versus human TLR4-MD2-CD14 ( Figure 1B) .
To follow up on the NF-kB activation studies, we compared the capacity of different doses of LOS purified from B. pertussis strains BP338 and 18-323 and E. coli K12 to induce the release of interleukin (IL)-1b, IL-6, tumor necrosis factor (TNF)-a, and interferon (IFN)-g from human THP-1-derived macrophages. We found that LOS from both B. pertussis BP338 and E. coli K12 induced IL-1b, IL-6, TNF-a, and low amounts of IFN-g, whereas LOS from B. pertussis 18-323 did not ( Figure  2 ). This result was reminiscent of what we observed with BP338GlcN Ϫ [12] .
When we stimulated the murine macrophage cell line RAW 264.7 with different doses of purified LOS from B. pertussis 18-323 or BP338 or E. coli K12, the latter was again found to be the most potent inducer of IL-6 and TNF-a, followed by BP338 LOS, whereas 18-323 LOS was found to be greatly impaired in inducing the secretion of these cytokines, even more so than purified LOS from BP338GlcN Ϫ (Figure 3 ).
Our findings that 18-323 LOS poorly stimulated human TLR4-MD-2-CD14 ( Figure 1 ) prompted us to ask whether purified 18-323 LOS can antagonize the biological activity of the canonical E. coli O111:B4 endotoxin to activate NF-kB. We stimulated transfected HEK-293 cells that expressed either human or murine TLR4-MD-2-CD14 with a constant concentration of purified LPS from E. coli O111:B4, alone or combined with increasing concentrations of either 18-323 or BP338 LOS, R. sphaeroides LPS, or synthetic lipid IV A . The latter 2 stimuli are known antagonists, R. sphaeroides LPS of both human and murine TLR4-MD-2-CD14 and lipid IV A of human but not murine TLR4-MD-2-CD14 [26, 27] . Indeed, whereas there was only moderate inhibitory activity with BP338 LOS with the human receptor and no inhibition with the murine receptor, 18-323 LOS markedly inhibited the ability of E. coli endotoxin to activate NF-kB in a dose-dependent manner in HEK-293 cells expressing either human or murine receptors (Figure 4 ). The antagonism effect was less pronounced on HEK-293 cells expressing the murine receptor, where 18-323 LOS has modest agonist activity in this assay (Figures 1 and 4) . Inactivated B. pertussis organisms, which serve as the antigen component for the still widely used DTwP vaccines, contain other heat-stable TLR ligands (eg, bacterial lipoproteins) in addition to LOS. To take these influences into account, we assessed the ability of heat-killed bacteria at varying doses to induce the release of the proinflammatory cytokines IL-1b, IL-6, and TNF-a, as well as IFN-g in THP-1-derived macrophages. In comparison to BP338, we found heat-killed 18-323 exhibited a significantly diminished capacity to elicit similarly high levels of all the cytokines tested, except TNF-a after 4 h of stimulation ( Figure 5 ).
Finally, we identified differences in the LOS structures of B. pertussis strains BP338 and 18-323 which explain their distinct biological activities. Negative ion MALDI mass spectra of LOS and lipids A isolated from wild-type strains BP338 and 18-323 were compared ( Figure 6 ). Peaks corresponding in majority to penta-acyl lipids A containing GlcN substituents (m/z, 1720 and 1881) were found in a large amount in the lipid A spectrum from BP338 ( Figure 6A ). They were absent in the lipid A spectrum from strain 18-323 ( Figure 6B ), indicating that 18-323 LOS does not bear GlcN substituents on its lipid A phosphate groups. Surprisingly, the spectrum obtained from strain 18-323 also revealed that the molecular species corresponding to pentaacyl lipid A with free phosphate groups at m/z 1559 in BP338 is shifted to m/z 1503 and 1531, indicating an additional structural variability in the lipid A of this strain. Negative ion MALDI mass spectra of lipid A of 18-323 obtained after sequential liberation of the fatty acids and fragmentation data obtained in positive-ion mode (data not shown) indicated that in this strain, the C3 position of the diglucosamine backbone is substituted, either with C10-OH or with C12-OH. The C3 position remained unchanged, substituted with a C10-OH. This is different from lipids A of Tohama I derivative BP338 and strain 1414, both of which bear C10-OH in C3 and C14-OH in C3 positions, respectively [11, 30, 31] . Fatty acid analysis of the lipid A of this strain confirmed the differences displayed on the spectra. The lipid A structures are illustrated in figure 6E . Furthermore, comparison of the MALDI mass spectra of BP338 and 18-323 LOS revealed a structural difference in the polysaccharide moiety of their LOS ( Figure 6C and 6D) . A series of additional peaks was observed in the polysaccharide region of the 18-323 LOS MALDI mass spectrum (m/z, 1598, 1641, 2039, 2261, and 2304) and shifted 192 u lower to the common peaks (m/z, 1790, 1833, 2231, 2453, and 2496) of the wellknown nona-and dodecasaccharide species [30] . This observation indicates the presence of molecular species missing the terminal heptose among the 18-323 LOS molecules.
DISCUSSION
In the present study, we found that in comparison to the commonly used Tohama I laboratory strain BP338, the mouse challenge strain 18-323 was significantly impaired in its ability to activate transcription factor NF-kB in transfected HEK-293 cells Comparison of heat-killed whole bacteria preparations to defined lipopolysaccharide preparations by densitometry of silver-stained [28] tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis [29] revealed that the highest dose (multiplicity of infection [MOI], 750) contained ∼25 mg/mL lipooligosaccharide and the lower doses contained 2.5 and 0.25 mg/mL lipooligosaccharide, respectively. IFN, interferon; IL, interleukin; TNF, tumor necrosis factor. that expressed human or murine TLR4-MD-2-CD14 when whole inactivated cells or purified LOS were used as stimuli. This difference appeared more pronounced on recognition of human versus murine TLR4-MD-2-CD14. Previously, we demonstrated that BP338GlcN Ϫ , a mutant which lacks the ability to modify its lipid A phosphate groups with GlcN, is impaired in its capacity to activate NF-kB in HEK-293 cells that express human TLR4-MD-2-CD14 [12] (although to a lesser extent than B. pertussis 18-323). However, in contrast to our present findings with 18-323, HEK-293 cells expressing murine TLR4-MD-2-CD14 were found to be equally and highly responsive to whole inactivated BP338 and BP338GlcN Ϫ cells or purified LOS from them [12] . Accordingly, we found that purified LOS from BP338 and 18-323 have significantly different capacities to induce the release of proinflammatory cytokines from human and murine macrophages. Indeed, in contrast to BP338 LOS, 18-323 LOS lacked the capacity to induce the release of IL-1b, IL-6, TNF-a, and IFN-g in THP-1-derived macrophages at any of the doses tested here. This lack of cytokine-stimulatory activity of 18-323 LOS is similar to what we observed previously with LOS purified from mutant BP338GlcN Ϫ [12] . We also found inactivated BP338 and 18- 323 cells to be significantly different in their capacities to induce the release of the same proinflammatory cytokines from human (THP-1-derived) macrophages. Cytokine induction in response to inactivated 18-323 cells (albeit to significantly lower levels in comparison to BP338) but not to purified 18-323 LOS, was likely attributable to the presence of heat-stable TLR ligands other than LOS in whole cell preparations (ie, bacterial lipoprotein). For example, both BP338 and 18-323 inactivated cells were equally potent activators of NF-kB in HEK-293 cells that expressed murine TLR2 and TLR6 (data not shown). Interestingly, like R. sphaeroides LPS, purified 18-323 LOS antagonized the biological activity of canonical E. coli endotoxin to activate NF-kB in HEK-293 cells, which was most pronounced in cells expressing human TLR4-MD-2-CD14 and only modest in cells expressing murine TLR4-MD-2-CD14. We speculate that LOS from both BP338 and 18-323 bind to the human or murine TLR4-MD-2-CD14 receptor complex; however, the latter LOS structure is largely unable to induce the formation of 2 symmetrically arranged receptor heterodimers of human TLR4-MD-2 and only modestly induces murine TLR4-MD-2 heterodimerization. Heterodimerization promotes signal activation through recruitment of intracellular adapter proteins such as MyD88 [32] . It is increasingly recognized that lipopoly-and oligosaccharides of gram-negative bacteria can vary greatly in their biological activity because of structural differences, particularly in their lipid A moiety [33] [34] [35] . In contrast to BP338, 18-323 lacks the ability to modify its lipid A phosphate groups with GlcN, and whereas the lipid A diglucosamine backbone of BP338 is substituted with C14-OH at the C-3 position [11, 30, 31] , that of 18-323 is substituted with either C10-OH or C12-OH at this position. MALDI MS obtained from 18-323 LOS also indicate the presence of molecular species missing the terminal heptose. Because the TLR4-MD-2-CD14 receptor binds primarily the lipid A moiety [32] , the latter difference likely has little impact on recognition via TLR4-MD-2-CD14. The genetic basis for the distinct LOS structure of B. pertussis 18-323 and how this affects receptor engagement is currently under investigation.
Taken together, we demonstrate for the first time that, in comparison to other B. pertussis strains, 18-323 exhibits remarkably low endotoxicity because of structural differences in its LOS. Our findings should be taken into account when interpreting previously published studies of host defenses to infection with different B. pertussis strains. For example, live and heat-inactivated 18-323 was previously reported to induce human monocyte-derived dendritic cells (MDDCs) to mature and to produce a T helper 1-biased cytokine profile in vitro [36] , mainly because of the action of the adenylate cyclase toxin [37] . The same group reported in 2 later studies that purified B. pertussis LOS induces human MDDCs to mature and to drive T helper 2-biased T cell responses [38] and T helper 17 polarization [39] ; in these later 2 studies, they used purified LOS from B. pertussis BP338 instead. Given that 18-323 LOS lacked biological activity in our study, whereas BP338 LOS did not, it will be interesting to elucidate the effect of live and heatkilled B. pertussis BP338 on MDDC maturation and cytokine profiles.
On the basis of genotypic and phenotypic differences from other B. pertussis isolates [14, [16] [17] [18] , the suitability of B. pertussis 18-323 as a challenge strain for assessing the efficacy of pertussis vaccines in the mouse model has been questioned in the past [15] . Nevertheless, one of the major reasons for establishing B. pertussis 18-323 as the mouse challenge strain has been its high virulence when used to challenge mice intracerebrally [13] . Given the role of TLR4 signaling in clearance of B. pertussis in mice [7] , one could speculate that the low endotoxicity of 18-323 may be a major contributing factor for its high virulence when used for the intracerebral challenge of mice [13] ; this needs further investigation.
Because reactogenicity of conventional DTwP vaccines is well correlated with endotoxicity [10] , it is also tempting to speculate that DTwP vaccines formulated with B. pertussis 18-323 may be less reactogenic than those formulated with other B. pertussis strains. However, this remains to be tested. To our knowledge, no such vaccine has been manufactured and clinically evaluated. B. pertussis 18-323 is capable of expressing important vaccine antigens [40] [41] [42] , and research vaccines formulated with 18-323 have similar vaccine potency in the murine intracerebral challenge model as vaccines formulated with other B. pertussis isolates [43] . Because the less reactogenic acellular pertussis-component vaccines are not affordable in most developing countries where 90% of all pertussis cases occur [2] , improvement of the safety of whole-cell pertussiscomponent vaccines by lowering their endotoxicity remains a desirable goal [44, 45] .
